Literature DB >> 14694093

Genetic and biochemical analysis of cis regulatory elements within the keratinocyte enhancer region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.

Ellora Sen1, Samina Alam, Craig Meyers.   

Abstract

Using linker scanning mutational analysis, we recently identified potential cis regulatory elements contained within the 5' upstream regulatory region (URR) domain and auxiliary enhancer (AE) region of the human papillomavirus type 31 (HPV31) URR involved in the regulation of E6/E7 promoter activity at different stages of the viral life cycle. For the present study, we extended the linker scanning mutational analysis to identify potential cis elements located in the keratinocyte enhancer (KE) region (nucleotides 7511 to 7762) of the HPV31 URR and to characterize cellular factors that bind to these elements under conditions representing different stages of the viral life cycle. The linker scanning mutational analysis identified viral cis elements located in the KE region that regulate transcription in the presence and absence of any viral gene products or viral DNA replication and determine the role of host tissue differentiation on viral transcriptional regulation. Using electrophoretic mobility shift assays, we illustrated defined reorganization in the composition of cellular transcription factors binding to the same cis regulatory elements at different stages of the HPV differentiation-dependent life cycle. Our studies provide an extensive map of functional elements in the KE region of the HPV31 URR, identify cis regulatory elements that exhibit significant transcription regulatory potential, and illustrate changes in specific protein-DNA interactions at different stages of the viral life cycle. The variable recruitment of transcription factors to the same cis element under different cellular conditions may represent a mechanism underlying the tight link between keratinocyte differentiation and E6/E7 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14694093      PMCID: PMC368763          DOI: 10.1128/jvi.78.2.612-629.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation.

Authors:  C Meyers; M G Frattini; J B Hudson; L A Laimins
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes.

Authors:  M Hummel; J B Hudson; L A Laimins
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements.

Authors:  M Walters; D I Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

4.  Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes.

Authors:  F Thierry; G Spyrou; M Yaniv; P Howley
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription.

Authors:  D Ron; J F Habener
Journal:  Genes Dev       Date:  1992-03       Impact factor: 11.361

6.  NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region.

Authors:  S Kyo; M Inoue; Y Nishio; K Nakanishi; S Akira; H Inoue; M Yutsudo; O Tanizawa; A Hakura
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

7.  Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses.

Authors:  D V Heck; C L Yee; P M Howley; K Münger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

8.  Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1.

Authors:  T Bauknecht; P Angel; H D Royer; H zur Hausen
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

9.  Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.

Authors:  T Ishiji; M J Lace; S Parkkinen; R D Anderson; T H Haugen; T P Cripe; J H Xiao; I Davidson; P Chambon; L P Turek
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

10.  A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.

Authors:  M Boshart; L Gissmann; H Ikenberg; A Kleinheinz; W Scheurlen; H zur Hausen
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  10 in total

Review 1.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

2.  Study of infectious virus production from HPV18/16 capsid chimeras.

Authors:  Horng-Shen Chen; Jennifer Bromberg-White; Michael J Conway; Samina Alam; Craig Meyers
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

3.  Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.

Authors:  Brian S Bowser; Horng-Shen Chen; Michael J Conway; Neil D Christensen; Craig Meyers
Journal:  Virus Res       Date:  2011-07-06       Impact factor: 3.303

4.  Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter.

Authors:  Jason M Bodily; Craig Meyers
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  HPV type 16 E6 and NFX1-123 augment JNK signaling to mediate keratinocyte differentiation and L1 expression.

Authors:  Justine Levan; Portia A Vliet-Gregg; Kristin L Robinson; Lisa R Matsumoto; Rachel A Katzenellenbogen
Journal:  Virology       Date:  2019-03-16       Impact factor: 3.616

6.  Characterization of transcription factor binding to human papillomavirus type 16 DNA during cellular differentiation.

Authors:  Andrew Carson; Saleem A Khan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  Control of the papillomavirus early-to-late switch by differentially expressed SRp20.

Authors:  Rong Jia; Xuefeng Liu; Mingfang Tao; Michael Kruhlak; Ming Guo; Craig Meyers; Carl C Baker; Zhi-Ming Zheng
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

8.  The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes.

Authors:  Michael J Lace; James R Anson; Gregory S Thomas; Lubomir P Turek; Thomas H Haugen
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

9.  Functional mapping of the human papillomavirus type 16 E1 cistron.

Authors:  Michael J Lace; James R Anson; Lubomir P Turek; Thomas H Haugen
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

10.  Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin.

Authors:  Nitesh Mistry; Monika Simonsson; Magnus Evander
Journal:  Virol J       Date:  2007-03-12       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.